Rob Sederman | CEO
Ambit RD, Inc
Current CEO at Ambit 30+ years of experience in biopharma consulting and analytics Prior Roles: - VP, Head of Commercial Strategy and Analytics, CRA - Founder and Managing Director, C1 Consulting - Founder and CEO, Cozint - Partner, ZS Associates - MBA, Harvard University; BS, USAF Academy
Appearances:
Day 1 - World Orphan Drug Congress USA 2026 @ 12:10
Fast-Track Rare Disease Patient Identification
Commercial and clinical teams need to identify and activate rare disease patients faster, yet traditional approaches often fall short, delaying trials and launches. This session presents a new model for rare disease patient identification. Discover how Ambit’s Patient Activate platform integrates real-world signals and guided engagement to reach and activate patients conventional direct-to-patient tactics miss, accelerating connection and improving outcomes
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events